Literature DB >> 19098374

Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the suita study.

Yoshihiro Kokubo1, Tomonori Okamura, Yasunao Yoshimasa, Yoshihiro Miyamoto, Katsuyuki Kawanishi, Yasushi Kotani, Akira Okayama, Hitonobu Tomoike.   

Abstract

Abdominal obesity is a prerequisite for some definitions of metabolic syndrome (MetS). We investigated the impact of MetS defined by two different criteria, which either did or did not require abdominal obesity as a prerequisite, on cardiovascular disease (CVD) incidence in an urban Japanese cohort study. We studied 5,332 Japanese (aged 30-79 years, without CVD at baseline), who completed a baseline survey (September 1989 to March 1994) and were followed up through December 2005. MetS was defined by the NCEP-ATPIII (modified by Asian obesity criteria) and the Japanese criteria. After 61,846 person-years of follow-up, we documented 317 CVD incidences. The MetS frequencies of the Japanese and of the modified NCEP-ATPIII criteria were 17.7% and 25.1% for men and 5.0% and 14.3% for women, respectively. The multivariate hazard ratios (HRs; 95% confidence intervals [CI]) of CVD incidence for MetS by the modified NCEP-ATPIII criteria were 1.75 (1.27-2.41) in men and 1.90 (1.31-2.77) in women, and those for MetS by the Japanese criteria were 1.34 (0.96-1.87) in men and 2.20 (1.31-3.68) in women. The multivariate HRs of CVD incidence for MetS for the Japanese and for the modified NCEP-ATPIII criteria were 2.92 (1.54-5.55) and 1.94 (0.98-3.82) in men under 60 years old, respectively. The CVD incidence risks increased according to the number of MetS components. The risks were similar among participants with the same number of MetS components, regardless of abdominal obesity. In conclusion, the number of MetS components (modified NCEP-ATPIII criteria) may be more strongly associated with CVD incidence than the abdominal obesity essential criteria (the Japanese criteria) in a general urban Japanese population. (Hypertens Res 2008; 31: 2027-2035).

Entities:  

Mesh:

Year:  2008        PMID: 19098374     DOI: 10.1291/hypres.31.2027

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  22 in total

1.  Cholesteryl ester transfer protein, coronary calcium, and intima-media thickness of the carotid artery in middle-age Japanese men.

Authors:  Tomonori Okamura; Akira Sekikawa; Takashi Kadowaki; Aiman El-Saed; Robert D Abbott; J David Curb; Daniel Edmundowicz; Yasuyuki Nakamura; Kiyoshi Murata; Atsunori Kashiwagi; Kim Sutton-Tyrrell; Rhobert W Evans; Joseph M Zmuda; Hiroshi Maegawa; Atsushi Hozawa; Ken-Ichi Mitsunami; Yoshihiko Nishio; Iva Miljkovic-Gacic; Minoru Horie; Naomi Miyamatsu; Yoshitaka Murakami; Lewis H Kuller; Hirotsugu Ueshima
Journal:  Am J Cardiol       Date:  2009-07-18       Impact factor: 2.778

2.  Abnormality of risk factors for atherosclerotic disease among young Japanese aged 19-39 years old: an evaluation of health checkup data.

Authors:  Kemal Sasaki; Aya Yoshida; Hiroshi Ohta; Yoshiharu Aizawa; Akiko Kojima; Hitomi Chiba; Shin Mizuguchi; Tatsunori Ishidzuka; Hiroshi Goto; Chiho Uegaki; Kyuhei Kotake
Journal:  Environ Health Prev Med       Date:  2012-07-04       Impact factor: 3.674

Review 3.  The Lifelong Health Support 10: a Japanese prescription for a long and healthy life.

Authors:  Ahmed Arafa; Yoshihiro Kokubo; Rena Kashima; Masayuki Teramoto; Yukie Sakai; Saya Nosaka; Youko M Nakao; Emi Watanabe
Journal:  Environ Health Prev Med       Date:  2022       Impact factor: 4.395

4.  Weight Change Since Age 20 and the Risk of Cardiovascular Disease Mortality: A Prospective Cohort Study.

Authors:  Ahmed Arafa; Yoshihiro Kokubo; Haytham A Sheerah; Yukie Sakai; Emi Watanabe; Jiaqi Li; Kyoko Honda-Kohmo; Masayuki Teramoto; Rena Kashima; Masatoshi Koga
Journal:  J Atheroscler Thromb       Date:  2021-11-20       Impact factor: 4.394

5.  Prevalence of metabolic syndrome in elderly Japanese-Brazilians.

Authors:  Natasha Priscilla Xavier; Rita Cristina Chaim; Suely Godoy Agostinho Gimeno; Sandra Roberta Gouvea Ferreira; Amelia Toyomi Hirai; Camila Moreno Rosa; Carlos Roberto Padovani; Marina Politi Okoshi; Katashi Okoshi
Journal:  Med Sci Monit       Date:  2012-02

6.  Risk Classification for Metabolic Syndrome and the Incidence of Cardiovascular Disease in Japan With Low Prevalence of Obesity: A Pooled Analysis of 10 Prospective Cohort Studies.

Authors:  Hiroyasu Iso; Renzhe Cui; Iseki Takamoto; Masahiko Kiyama; Isao Saito; Tomonori Okamura; Yoshihiro Miyamoto; Aya Higashiyama; Yutaka Kiyohara; Toshiharu Ninomiya; Michiko Yamada; Hideaki Nakagawa; Masaru Sakurai; Michio Shimabukuro; Moritake Higa; Kazuaki Shimamoto; Shigeyuki Saito; Makoto Daimon; Takamasa Kayama; Mitsuhiko Noda; Sadayoshi Ito; Koutaro Yokote; Chikako Ito; Kazuwa Nakao; Toshimasa Yamauchi; Takashi Kadowaki
Journal:  J Am Heart Assoc       Date:  2021-11-19       Impact factor: 6.106

7.  Adiposity and risk of cardiovascular diseases in Japan: secular trend, individual level associations and causal pathway - implications for the prevention of cardiovascular diseases in societies with rapid economic development.

Authors:  Hiroshi Yatsuya; Kazumasa Yamagishi; Hiroyasu Iso
Journal:  EPMA J       Date:  2011-03-27       Impact factor: 6.543

8.  Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment?

Authors:  Yoshihiro Kokubo
Journal:  EPMA J       Date:  2011-04-02       Impact factor: 6.543

9.  A Japanese health success story: trends in cardiovascular diseases, their risk factors, and the contribution of public health and personalized approaches.

Authors:  Hiroyasu Iso
Journal:  EPMA J       Date:  2011-03-24       Impact factor: 6.543

10.  Association between stroke and metabolic syndrome in a Japanese population: Jichi Medical School (JMS) Cohort Study.

Authors:  Yasunori Niwa; Shizukiyo Ishikawa; Tadao Gotoh; Kazunori Kayaba; Yosikazu Nakamura; Eiji Kajii
Journal:  J Epidemiol       Date:  2009-12-05       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.